RF Industries, Ltd. (NASDAQ:RFIL) announced preliminary unaudited financial results for the fiscal fourth quarter and year ended October 31, 2013. RF Industries, Ltd. (NASDAQ:RFIL) stock opened at $6.85 in last trading session, and closed at $6.84, trading in the range of $6.27 – $7.15. The stock showed a negative weekly performance of -23.66%.
Equities research analysts at JMP Securities initiated coverage on shares of Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) in a research note issued to investors on Thursday, AnalystRatingsNetwork.com reports. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) shares closed at $3.50 on last trade day, by losing -14.63%. Stock 52 week range is $0.76 – $4.53. Company’s market capitalization is $274.52 billion.
TheStreet Quant Ratings rates Inovio Pharmaceuticals as a sell. The company’s weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity and poor profit margins. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock plunged -12.89% and finished the last session at $2.50. The EPS of the stock remained -0.28. Company’s market capitalization is $520.94 million.
At the Annual Meeting of Shareholders of Gyrodyne Company of America, Inc. (NASDAQ:GYRO) held on December 27, 2013, the Company’s shareholders voted on the matters set forth below. Each issued common share was entitled to one vote on the proposals voted on at the 2013 Meeting. Of the 1,482,680 shares of the Company’s common stock outstanding and eligible to vote at the 2013 Meeting, 1,321,673 shares, or 89.14% of the eligible common stock, were present either in person or by proxy. Gyrodyne Company of America, Inc. (NASDAQ:GYRO) stock opened at $11.50 in last trading session and closed at $10.79. The 52 week range of the stock is $10.70 – 80.04 and the day range was $10.70 – $11.50.